课题基金 / 基金详情

ANTI SENSE INHIBITION OF HBSAG EXPRESSION IN HEP G2 CELL

ANTI SENSE INHIBITION OF HBSAG EXPRESSION IN HEP G2 CELL
HEP G2 细胞中 HBSAG 表达的反义抑制
批准号:
3489427
负责人:
HOWARD Byron GAMPER
金额:
$4.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1992-07-31

项目摘要

项目成果

HOWARD Byron GAMPER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):唯一修改
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Uniquely modified anti-sense oligodeoxynucleotides (ODNs) targeted to the hepatitis B surface antigen transcript will be evaluated in a differentiated hepatoma cell line which supports the constituitive production of infectious Dane particles. Inhibition of surface antigen production will be monitored by analyzing aliquots of the media for hepatitis B surface antigen using a commercially available ELISA kit. ODN modifications to be examined will consist of alkyl side arms terminating in amino, cholesterol, or acridine groups. These arms will be introduced singly or in combination at 5', 3', and internal sites of the ODN. Selected ODNs will be complexed with an asialoorosomucoid-poly-L-lysine conjugate previously shown to promote receptor-mediated internalization of DNA in hepatocytes. The effect of this delivery system on the potency of the anti-sense effect and on the stability and cellular uptake of each ODN will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reagents for Preparing Structure-Free DNA and RNA
  • 批准号:
    6937355
  • 项目类别:
  • 资助金额:
    $9.99万
  • 财政年份:
    2005
  • 负责人:
    HOWARD Byron GAMPER
  • 依托单位:
Reagents for Preparing Structure-Free DNA and RNA
  • 批准号:
    7089166
  • 项目类别:
  • 资助金额:
    $37.45万
  • 财政年份:
    2005
  • 负责人:
    HOWARD Byron GAMPER
  • 依托单位:
Reagents for Preparing Structure-Free DNA and RNA
  • 批准号:
    7162614
  • 项目类别:
  • 资助金额:
    $37.29万
  • 财政年份:
    2005
  • 负责人:
    HOWARD Byron GAMPER
  • 依托单位:
HIV REPORTER CELL LINE FOR SCREENING ANTI-SENSE AGENTS
  • 批准号:
    3489465
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    1991
  • 负责人:
    HOWARD Byron GAMPER
  • 依托单位:
海外基金